AIM ImmunoTech (AIM) Operating Income (2018 - 2023)
Historic Operating Income for ImmunoTech (AIM) over the last 6 years, with Q4 2023 value amounting to -$14.0 million.
- ImmunoTech's Operating Income changed N/A to -$14.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$28.9 million, marking a year-over-year change of. This contributed to the annual value of -$19.8 million for FY2024, which is 3804.99% up from last year.
- Per ImmunoTech's latest filing, its Operating Income stood at -$14.0 million for Q4 2023.
- ImmunoTech's 5-year Operating Income high stood at -$3.3 million for Q1 2020, and its period low was -$14.0 million during Q4 2023.